Sequencing of MET Inhibitors in Lung Cancer: Have We Met the Target?

J Thorac Oncol. 2021 May;16(5):709-711. doi: 10.1016/j.jtho.2021.02.017.

Authors

Chang Gon Kim¹, Byoung Chul Cho¹, Sun Min Lim²

Affiliations

¹ Division of Medical Oncology, Department of Internal Medicine, Yonsei Cancer Center, Yonsei University College of Medicine, Seoul, South Korea.
² Division of Medical Oncology, Department of Internal Medicine, Yonsei Cancer Center, Yonsei University College of Medicine, Seoul, South Korea. Electronic address: limlove2008@yuhs.ac.

PMID: 33896567
DOI: 10.1016/j.jtho.2021.02.017

No abstract available

Publication types

Editorial
Comment

MeSH terms

Benzamides
Humans
Imidazoles
Lung Neoplasms* / drug therapy
Protein Kinase Inhibitors / therapeutic use
Triazines

Substances

Benzamides
Imidazoles
Protein Kinase Inhibitors
Triazines
capmatinib